Mingocare 4 mg tabl. prol.-rel.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Fesoterodine Fumarate 4 mg - Eq. Fesoterodine 3,1 mg
Available from:
Ceres Pharma SA-NV
ATC code:
G04BD11
Pharmaceutical form:
Prolonged-release tablet
Administration route:
Oral use
Therapeutic area:
Fesoterodine
Product summary:
CTI Extended: 660954-07; 660954-01; 660954-02; 660954-04; 660954-06; 660954-08; 660954-05; 660954-03
Authorization status:
Commercialised: No
Authorization date:
2022-12-23
